Dr. Andrius Baskys, MD

Dr. Baskys practices at Westernu Health in Pomona, California.

Dr. Baskys' NPI, 1124110069, was assigned on September 29, 2006. Dr. Baskys graduated from Vilnius University Faculty of Medicine in 1975. Dr. Baskys' California license number on file is A64874.

Dr. Baskys' primary practice is Westernu Health, at 795 E 2nd St Suite 2 Suite 2, Pomona, CA 91766-2007. The practice phone is (909) 469-8673.

Dr. Baskys' primary practice is Westernu Health in Pomona, California. The medical group on file is OC Health Care Agency. Dmand AI also links Dr. Baskys to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baskys practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Baskys' primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Baskys is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Baskys' licenses on file in 2 states: California and Michigan.

Dmand AI lists anxiety, bipolar disorder, depression, intellectual and developmental disabilities, non-alzheimer's dementia (chronic) and schizophrenia among the conditions Dr. Baskys treats.

CMS data shows 122 Medicare services from Dr. Baskys across 2 procedure codes in 2024, for 30 Medicare patients. Medicare paid $11,945 for them. Every service was in an office.

CMS counts 30 Medicare patients who saw Dr. Baskys in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have depression, and 75% have mood disorders. 53% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baskys' median patient age at 66, with 56% women.

In 2024, Dr. Baskys wrote 755 Medicare Part D claims for 63 patients. 94% of them were for generic drugs. CMS names the drug for 653 of them, across 22 drugs with 11 or more claims each, at $54,296 in total drug cost. In 2023, CMS named 577 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Baskys for performance year 2024, reported as part of a group. Dr. Baskys accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baskys as offering telehealth.

Dmand AI links 43 papers to Dr. Baskys, published from 2011 to 2023. 2021 was the busiest year, with 3. The most frequent topics are Hippocampus, In Vitro Techniques and Neuroprotective Agents. Dr. Baskys has published most often in Brain Res. Dr. Baskys' most frequent co-authors are Sarah Pospos, MD, MS, Ricardo E. Jorge, MD and Warren Douglas Taylor, MD.

CMS Open Payments shows 25 general payments to Dr. Baskys from 16 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 86% of the total. Sanofi and Genzyme US Companies paid the most, $8,305.

Dr. Baskys graduated from Vilnius University Faculty of Medicine in 1975.

Dr. Baskys is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.